*To be consumed as directed by physician.
Therapies:
Supportive
Composition:
Aprepitant (125 mg) + Aprepitant (80 mg)
Apretero 125/80 mg Capsule contains Aprepitant, an NK1 receptor antagonist used to inhibit nausea and vomiting during chemotherapy. It is suggested in combination with other anti-cancer medicines to improve patient comfort during cancer treatment. By mitigating the action of substance P, a chemical involved in triggering nausea and vomiting, Aprepitant lowers treatment-related discomfort and supports better adherence to chemotherapy regimens in adults and children aged 12 years and above.
*To be consumed as directed by physician.